Palivizumab injection (Synagis), an RSV prevention therapy for children, is being discontinued and will no longer be available as of December 31, 2025.

Nationally, 25% of patients admitted to the hospital from the emergency department have to wait 4 hours or more for a bed during nonpeak months.

The sodium chloride 0.9 percent injection shortage is resolved, and it will be removed from the FDA Drug Shortage Database; facilities are advised to use FDA-approved products when available. The FDA ...

With new systemic treatments now available for psoriatic disease, questions remain on the comparable efficacy and safety of these therapies.

Among patients with chronic hepatitis C virus (HCV), post-sustained virologic response (SVR) hepatocellular carcinoma (HCC) risk is significantly higher with metabolic dysfunction-associated steatotic ...

Physician attire impacts patients' perceptions of professionalism, trust, and communication, but perceptions are highly context-dependent.